Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-opioid pain medications after adenotonsillectomy
NCT03618823Phase 2Terminated
- Start
- Oct 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of oxycodone in postoperative pain. Primary endpoint: Average Pain Burden at 14 days. Started Oct 2018; status: terminated.
02
Drugs
oxycodone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03618823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03618823.